Khursheed Anwer - Mar 15, 2024 Form 4 Insider Report for Imunon, Inc. (IMNN)

Role
Chief Scientific Officer
Signature
/s/ Kimberly Graper, VP of Finance & Controller
Stock symbol
IMNN
Transactions as of
Mar 15, 2024
Transactions value $
$0
Form type
4
Date filed
3/18/2024, 05:10 PM
Previous filing
Mar 21, 2023
Next filing
Jun 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNN Stock Option (Right to Buy) Award $0 +25K +29.18% $0.00 111K Mar 15, 2024 Common Stock 25K $0.86 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.
F2 Represents the closing price of Imunon, Inc. Common Stock on the date of grant.